Academic Journals Database
Disseminating quality controlled scientific knowledge

Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic

ADD TO MY LIST
 
Author(s): Burke Ronald | Vest Kelly | Eick Angelia | Sanchez Jose | Johns Matthew | Pavlin Julie | Jarman Richard | Mothershead Jerry | Quintana Miguel | Palys Thomas | Cooper Michael | Guan Jian | Schnabel David | Waitumbi John | Wilma Alisa | Daniels Candelaria | Brown Matthew | Tobias Steven | Kasper Matthew | Williams Maya | Tjaden Jeffrey | Oyofo Buhari | Styles Timothy | Blair Patrick | Hawksworth Anthony | Montgomery Joel | Razuri Hugo | Laguna-Torres Alberto | Schoepp Randal | Norwood David | MacIntosh Victor | Gibbons Thomas | Gray Gregory | Blazes David | Russell Kevin

Journal: BMC Public Health
ISSN 1471-2458

Volume: 11;
Issue: Suppl 2;
Start page: S6;
Date: 2011;
VIEW PDF   PDF DOWNLOAD PDF   Download PDF Original page

ABSTRACT
Abstract The Armed Forces Health Surveillance Center’s Division of Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) supports and oversees surveillance for emerging infectious diseases, including respiratory diseases, of importance to the U.S. Department of Defense (DoD). AFHSC-GEIS accomplishes this mission by providing funding and oversight to a global network of partners for respiratory disease surveillance. This report details the system’s surveillance activities during 2009, with a focus on efforts in responding to the novel H1N1 Influenza A (A/H1N1) pandemic and contributions to global public health. Active surveillance networks established by AFHSC-GEIS partners resulted in the initial detection of novel A/H1N1 influenza in the U.S. and several other countries, and viruses isolated from these activities were used as seed strains for the 2009 pandemic influenza vaccine. Partners also provided diagnostic laboratory training and capacity building to host nations to assist with the novel A/H1N1 pandemic global response, adapted a Food and Drug Administration-approved assay for use on a ruggedized polymerase chain reaction platform for diagnosing novel A/H1N1 in remote settings, and provided estimates of seasonal vaccine effectiveness against novel A/H1N1 illness. Regular reporting of the system’s worldwide surveillance findings to the global public health community enabled leaders to make informed decisions on disease mitigation measures and controls for the 2009 A/H1N1 influenza pandemic. AFHSC-GEIS’s support of a global network contributes to DoD’s force health protection, while supporting global public health.
Affiliate Program     

Tango Rapperswil
Tango Rapperswil